The GLP-1 Side Effect List Your Doctor Skipped — Especially If You Are Over 45 and Caring for an Aging Parent
Educational Review: Her Parents Help Editorial Team
Content Type: Research-Informed Caregiver Support
🇪🇸 Versión en Español disponible aquí → La Lista de Efectos Secundarios del GLP-1 Que Tu Médico Omitió — Especialmente Si Tienes Más de 45 Años y Cuidas a un Padre Mayor
Introduction
You started it hoping for answers. Here is what nobody told you about taking GLP-1 medication when you are already running on empty.
Let me tell you something that does not show up in the clinical trials.
The clinical trials for GLP-1 medications — semaglutide, tirzepatide, the ones you have heard about, the ones your doctor may have prescribed or mentioned — were not conducted primarily on women over 45 who are also managing perimenopause, chronic caregiver stress, disrupted sleep, and the kind of appetite suppression that comes from being so busy taking care of everyone else that you sometimes forget to eat lunch.
They were conducted on people who, for the most part, had a significant appetite to suppress.
That is not you
Or maybe it is partially you. Maybe you are somewhere in the middle — you have the weight you want to address, the health goals that make sense, the prescription in hand. But something is off. It is not working the way you expected. Or it is working but differently. Or you have side effects that feel strange given that you were not eating much to begin with.
This article is for you. Written by someone who is also in this — taking tirzepatide, also not sure it is working, also wondering if the fasting I was already doing and the appetite I already did not have much of means this medication and my body have a more complicated relationship than the advertisements suggest.
This is not medical advice. This is a real conversation that your doctor probably did not have time for.
What GLP-1 Medications Actually Do
GLP-1 — glucagon-like peptide-1 — is a hormone your body naturally produces that signals fullness, slows gastric emptying, and regulates insulin. GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic and amplify this effect.
In simple terms: they make you feel full faster and keep food in your stomach longer so you naturally eat less.
The results in clinical trials have been significant — average weight loss of 15 to 22 percent of body weight over 68 weeks for some medications. These are real numbers. The medications work.
But — and this is the but your doctor may have glossed over — they work by suppressing appetite and slowing the rate at which your stomach empties. And if your appetite is already suppressed by perimenopause, by chronic stress, by the kind of distracted forgetting-to-eat that caregiving produces — the medication is working in a body that may not have much appetite to suppress.
The Side Effects Your Doctor Probably Mentioned
Nausea. The most common side effect especially in the first weeks. Usually improves as the body adjusts to the medication. Eating smaller amounts more slowly helps. Avoiding fatty or spicy foods helps. It can be significant for some women.
Vomiting. Less common but possible especially if you eat too quickly or too much.
Constipation. Because the medication slows gastric emptying it also slows the entire digestive process. Hydration and fiber intake become more important. Some women need additional support for this.
Diarrhea. Paradoxically some women experience this instead of or in addition to constipation. The gut is adjusting.
Fatigue. Particularly in the early weeks. The body is adapting.
Injection site reactions. Redness, itching, or discomfort at the injection site.
These are the standard side effects. They are real. They are manageable for most women. And they are what most doctors cover in the initial conversation.
Here is what the conversation often misses.
The Side Effects Your Doctor Probably Skipped
Muscle loss — and why it matters more at 45 than at 35.
GLP-1 medications cause weight loss. But weight loss is not the same as fat loss. Research shows that a significant portion of the weight lost on GLP-1 medications — potentially 25 to 40 percent — can be lean muscle mass rather than fat.
For a woman over 45 this is a serious concern that deserves serious attention.
Perimenopause already accelerates muscle loss through declining estrogen. Caregiving stress — through elevated cortisol — further promotes muscle breakdown. And now a medication that causes additional lean mass loss on top of both of those.
Without intentional intervention — specifically adequate protein intake and resistance exercise — GLP-1 medications can leave you lighter on the scale but weaker, with less metabolic reserve, and with a body that is harder to maintain going forward.
What to do: Talk to your doctor specifically about protein intake on GLP-1 medications. Most recommendations are 1.2 to 1.6 grams of protein per kilogram of body weight per day — significantly more than the average American woman consumes. Resistance training — even light resistance training — is not optional if you are on these medications at 45 plus. It is protective.
Appetite suppression on top of already suppressed appetite.
Here is the situation that does not get discussed enough.
Many sandwich generation women are not eating enough to begin with. Not because they are dieting. Because they are busy. Because stress suppresses appetite. Because perimenopause changes hunger signals. Because they made breakfast for everyone else and forgot about themselves.
Adding a medication whose primary mechanism is appetite suppression to a body that is already under-fueled can lead to insufficient caloric and nutritional intake. Not weight loss from fat. Depletion. Fatigue that goes beyond the normal adjustment period. Cognitive fog that does not lift. Weakness.
If you were already not eating much and the medication has reduced your appetite further — this is a conversation to have with your doctor. Tracking your actual intake for a week is information worth having.
Muscle cramps and weakness.
Related to the above — insufficient intake combined with GLP-1 effects can produce muscle cramps, weakness, and fatigue that go beyond the normal adjustment period. Electrolytes — sodium, potassium, magnesium — become important. Many women on GLP-1 medications who are also not eating enough become significantly depleted in these minerals.
Hair loss.
Rapid weight loss of any kind — including GLP-1 induced weight loss — can trigger telogen effluvium, a form of hair shedding that typically begins three to six months after significant weight loss or nutritional stress. This is temporary but can be distressing. Adequate protein intake reduces the risk.
Mood changes.
This one is complex and not fully understood. Some women report mood improvements on GLP-1 medications — there is emerging research on GLP-1 receptors in the brain and potential effects on mood and even addiction pathways. But some women report increased anxiety, irritability, or low mood.
For a woman who is already managing caregiver stress and perimenopause mood fluctuations, adding a medication that may affect mood requires monitoring.
The medication may not work the way you expect if your baseline is already low.
This is the one that is most personal and most honest.
If you were already fasting. If you already had little appetite. If you were already not eating much. The medication may produce very little additional appetite suppression because there was not much to suppress.
You may not lose weight at the rate the trials suggest. You may need a higher dose. You may find that the medication produces side effects without producing the expected results. This is not a failure. It is a pharmacology question — the drug is working on a system that was already functioning differently than the average trial participant.
This is worth discussing with your prescribing doctor specifically. Not accepting the standard titration schedule without conversation about your specific baseline.
The Bigger Question Underneath All of This
Why are you on this medication?
Not in a judgment way. In a genuinely curious way that you deserve to ask yourself.
Is it for weight loss specifically? For metabolic health — blood sugar regulation, cardiovascular risk reduction? For the emerging data on other potential benefits? All of these are valid reasons that deserve a real conversation with your doctor about whether this medication is the right tool for your specific situation.
Or is it — and this is the one worth sitting with — because you are living a life that is so demanding, so depleting, so focused on everyone else that your own body has become something you are trying to manage rather than something you are trying to nourish?
Caregiving takes an enormous physical and metabolic toll. So does perimenopause. So does chronic sleep deprivation. So does chronic stress. The weight that some sandwich generation women are trying to address with medication is sometimes the body's response to an unsustainable situation — not a problem that exists independently of that situation.
This is not a reason to not take the medication. It is a reason to take it alongside the other things — the sleep, the stress management, the nutrition, the medical partnership — rather than instead of them.
What to Ask Your Doctor
If you are on or considering a GLP-1 medication and you are over 45 and you are a caregiver here are the specific questions worth asking:
"How much protein should I be consuming daily on this medication given my age and activity level?"
"Should I be doing resistance training while on this medication and what does that look like given my schedule?"
"Given that I was already not eating much before starting, how should we think about monitoring whether I am getting adequate nutrition?"
"What should I watch for in terms of muscle loss and how do we assess that over time?"
"How does this medication interact with perimenopause specifically — are there things I should know about how my hormonal status affects how this drug works?"
"At what point do we reassess whether this medication is working for my specific situation?"
These are not difficult questions. They are the questions you deserve answers to
The Honest Bottom Line
GLP-1 medications are real and for many women they are genuinely helpful. The research is significant. The potential benefits — beyond weight loss, including cardiovascular and metabolic health — are real.
But they are not magic. And they are not one size fits all. And taking them at 45 plus while managing perimenopause and caregiving and disrupted sleep and already suppressed appetite requires a more nuanced conversation than most prescribing appointments allow for.
You deserve that conversation. You deserve a doctor who takes your specific situation seriously rather than applying the standard protocol to a very non-standard set of circumstances.
You are not a clinical trial participant. You are a real woman in a real life. Your medication plan should reflect that.
Navigating your parent's aging while your own body is changing.
See where you stand as a caregiver.
Or check in with what your own body is going through right now.
Understand where you are in your hormone transition.
Related Articles
GLP-1 Medications and Muscle Loss in Women Over 40: How to Protect Lean Muscle During Weight Loss
Rapid Weight Loss Risks on GLP-1 Medications: What Women Over 40 Should Know
The Sandwich Generation Survival Guide — For the Woman Doing It All in the Middle
This article is part of the Her Parents Help and Her Midlife Wellness Help bridge series.
For more on midlife health and perimenopause visit Her Midlife Wellness Help. For caregiving support and resources visit Her Parents Help.
hermidlifewellnesshelp.com
The information on this page is for educational and informational purposes only and is not a substitute for professional medical advice. Always consult your doctor before starting, stopping, or changing any medication.
References & Sources
Wilding JPH et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. nejm.org
Jastreboff AM et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. nejm.org
Seibert SM et al. Lean Mass Changes with GLP-1 Receptor Agonists. pubmed.ncbi.nlm.nih.gov
North American Menopause Society. Muscle Mass and Menopause. menopause.org
Harvard Health Publishing. GLP-1 Drugs — What You Need to Know. health.harvard.edu
American College of Sports Medicine. Protein Recommendations for Adults Over 40. acsm.org
